ALBIO Share Price Performance
€0
-1.62 (-100.00%)
Price €0
Share Pricen/a
Biosynex SA's (EPA:ALBIO) Share Price Boosted 25% But Its Business Prospects Need A Lift Too
Jan 06
Biosynex SA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ALBIO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Biosynex SA Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -3.79
- 58.71%
- -72.47%
- 126.9%
About ALBIO
- Founded
- 1993
- Employees
- 454
- CEO
- WebsiteView website
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
